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suggesting that they reflect o some extent, distinct biological pro- 
cesses. 
Aim: to investigate whether Helix-II and CTX-II reflect distinct 
degradation mechanisms, prevailing differently in distinct areas of 
cartilage, and varying differently with age and menopausal status 
in healthy subjects. 
Methods: Immunohistochemistry was performed on full depth 
knee cartilage biopsies obtained from OA patients, and the tis- 
sue distribution of Helix-II and CTX-II immunoreactivitywas deter- 
mined. Urinary Helix-II and CTX-II were measured in 105 healthy 
women (from 26 to 90 years, mean: 59 years) and 48 healthy men 
(from 26 to 79 years, mean: 48 years). 
Results: Immunoreactivity for Helix-II, but not for CTX-II, was 
associated with the matrix of fibrillated articular surfaces. Adja- 
cent non-fibrillated surfaces were negative. Immunoreactivity for 
CTX-II, but not for Helix-II, was associated with matrix close to 
bone outgrowths into cartilage, often in areas of calcified carti- 
lage. Urinary levels of Helix-II did not change significantly with 
age or menopausal status in healthy women. Urinary levels of 
CTX-II were stable in healthy premenopausal women from age 35 
to menopause, but in contrast to Helix-II, increased markedly by 
an average of 70% (p<0.0001) after the menopause and then in- 
creased slightly but not significantly with age in postmenopausal 
women. In healthy men, there was no significant change with age 
both for urinary Helix-II and CTX-II. 
Conclusion: These differences in cartilage tissue distribution 
and relative urinary levels of Helix-II and CTX-II (i) support the 
existence of distinct mechanism of type II collagen breakdown 
during cartilage degradation; (ii) show that the prevailing break- 
down mechanism varies with the region of cartilage; and (iii) show 
that these mechanisms differ in their susceptibilities to age and 
menopause. Helix-II and CTX-II may provide distinct and com- 
plementary information on cartilage turnover. 
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Aim of Study: To determine the effect of estrogen and a 
SERM (LY505960) on the type II collagen biomarkers CTX-II and 
NET2C, in the rat ovariectomy (ovx) model and to investigate cor- 
relations between these two biomarkers. 
Methods: Forty-two 6-month-old female virgin Sprague Daw- 
ley rats underwent ovx and an additional 6 animals were sub- 
jected to sham ovx. Daily dosing began on day four post-ovx 
and consisted of the following eight groups (six animals/group): 
sham/vehicle, ovx/vehicle, ovx/17a-estradiol @ 0.01 and 0.10 
mg/kg, ovx/LY505960 @ 0.01, 0.10, 1.0 and 10.0 mg/kg. Prior 
to sacrifice (32 days post-ovx), overnight urines were collected. 
Urine samples from each animal were analyzed for type II col- 
lagen fragments containing the C-terminal telopeptide-derived 
peptide EKGPDP (CTX-II, Cartilaps: Nordic Bioscience Diagnos- 
tics A/S) by competition ELISA. The assay for a type II colla- 
gen neoepitope (NET2C) utilized online immunoaffinity capture 
with an antibody (9A4) specific for the collagenase-generated C- 
terminal neoepitope, followed by LC/MS/MS to quantify a spe- 
cific 14 mer collagen peptide (DGPSGSDGPPGPQG). CTX-II 
and NET2C concentrations in urine were normalized to creatinine 
levels. 
The data for each analyte were converted into pmoles/mole of 
creatinine and a Box-Cox transformation carried out in order to 
stabilize variances between groups to comply with standard sta- 
tistical ANOVA assumptions. A comparison of means was per- 
formed on the transformed ata using Dunnett's test for compar- 
ing each group to the non-dosed ovx group. 
Results: At 32 days post-ovx the CTX-II concentrations had in- 
creased 4.5 fold in the ovx animals while NET2C levels had in- 
creased 3.3 fold, compared with the sham-ovx animals (p<0.01). 
In comparison to the untreated ovx animals, both doses of 17a- 
estradiol and all doses of LY505960 significantly reduced both 
CTX-II levels and NET2C levels (p<0.01). A correlation coeffi- 
cient of 0.889 (regression R 2 = 0.7904) was obtained when the 
day 32 creatinine-adjusted values of CTX-II and NET2C values 
were plotted against each other. There was a small but statis- 
tically significant (p=0.0003) shift in the linear regression rela- 
tionship (CTX-II intercept at 0.69) and, a matched pairs analysis 
demonstrated that every treatment group except the sham-ovx 
group had higher CTX-II than NET2C values. 
Conclusions: We have extended previous reports relating 
to CTX-II in the ovx model, to demonstrate that NET2C, a 
collagenase-derived C-terminal type II collagen neoepitope, is el- 
evated in ovx rats and is sensitive to treatment with either estro- 
gen or the SERM, LY505960. Experimentally, a good correlation 
between CTX-II and NET2C was observed suggesting that re- 
lease of these two-type II collagen epitopes are temporally and 
mechanistically linked. The robust inhibition of type II collagen 
degradation by LY505960 in the rat ovx model suggests that this 
compound may be evaluated for treating osteoarthritis in post- 
menopausal women. 
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ADAMTS-7 DEGRADES COMP IN A Zn 2 +- AND 
pH-DEPENDENT MANNER AND IS SIGNIFICANTLY 
UPREGULATED IN THE CARTILAGE AND SYNOVlUM OF 
PATIENTS WITH RHEUMATOID ARTHRITIS 
C Liu, K Ilalov, B Sehgal, PE Di Cesare 
Orthopaedic Surgery, NYU-Hospital for Joint Diseases, New 
York, NY 
Study aims: Our genetic screen led to the discovery of ADAMTS- 
7 as an COMP-binding protein and ADAMTS-7 binds to the EGF 
domain of COMP via its C-terminal four TSP motifs. The purpose 
of this study was to characterize the mechanism underlying the 
ADAMTS-7-mediated COMP degradation and determine whether 
ADAMTS-7 expression was altered in the arthritic onditions. 
Methods: In vitro digestion assay: purified COMP (250nM) was 
incubated with recombinant ADAMTS-7 (25nM) in buffer (50mM 
Tris-HCI, 100mM NaCI, pH 7.5) supplemented with 5mM CaCI2, 
2mM ZnCL2, 2.5mM MgCI2, or various combinations at 37°C for 
12 hr. The digested proteins were visualized with Coomassie Blue 
R250. The same digestion was also performed at various pH val- 
ues. 
Subjects: Normal cartilage and synovium were obtained from 
the knees of four patients who died of diseases unrelated to 
arthritis. OA cartilage was obtained from the distal femora of 8 
patients and RA cartilage and synovium from the knees of 4 
RA patients. Expression of ADAMTS-7 in arthritic tissues: Real- 
time PCR was performed using a sequence-specific probe and 
primers for ADAMTS-7. 18s rRNA was used as internal control. 
PCR reactions were performed with 5 ng of cDNA, 100 nM probe, 
200 nM each primer, and 10.0 i~1 of TaqMan Universal 2' PCR 
Master Mix in a 20-1d reaction volume. 
Results: Zn 2+ is essential for the cleavage of COMP by 
ADAMTS-7- A degraded COMP fragment was detectable in the 
digestion buffer with Zn 2 +but was undetectable in the digestion 
buffer with Ca 2 + or Mg 2 + used alone. In the presence of Zn 2 +, 
the addition of Ca 2 +, but not Mg 2 +changed the electrophoretic 
